A Study of D3S-001 as Monotherapy in Subjects With Advanced Solid Tumors With a KRAS p.G12C Mutation
Condition(s):KRAS P.G12CLast Updated:November 30, 2023Recruiting
Include Studies Not Open or Pending
Condition(s):KRAS P.G12CLast Updated:November 30, 2023Recruiting
Condition(s):Vitamin D3 DeficiencyLast Updated:February 14, 2024Recruiting
Condition(s):Advanced Solid Tumors With MAPK Pathway MutationsLast Updated:March 15, 2024Recruiting
Condition(s):HER-2 Positive Advanced Solid TumorsLast Updated:February 1, 2024Recruiting
Condition(s):Vitamin D3; Advanced Cancer; Pain CancerLast Updated:August 31, 2023Recruiting
Condition(s):Lateral Epicondylitis of ElbowLast Updated:October 5, 2023Recruiting
Condition(s):Coronary Artery Disease; Carotid Artery DiseaseLast Updated:September 21, 2023Not yet recruiting
Condition(s):Gastric CancerLast Updated:November 22, 2023Recruiting
Condition(s):Obesity; Vitamin D3 DeficiencyLast Updated:January 19, 2023Recruiting
Condition(s):Complication; Quality of Life; Surgical Procedure, Unspecified; Lymph Node Metastases; Circulating Tumor CellLast Updated:August 25, 2021Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.